ACTIVE

Cryotherapeutics

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-2,3 M €-14,6 %over 1 year
Gross margin-29,2 k €-222,5 %over 1 year
Equity21,1 M €-9,7 %over 1 year
Workforce10,7 ETP+7,0 %over 1 year

Identity

Source · BCE/KBO

Cryotherapeutics is a Public limited company incorporated in 2018. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Ans. It employs on average 10,7 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0713.882.584
Incorporation
26/11/2018
Legal form
Public limited company
Registered office
Avenue Alfred Deponthière 46 box 21
4431 Ans · WallonieSee on map
Contributed capital
32 119 262,78 €
Latest accounts
31/12/2025
Average workforce
10,7 ETP
Joint committees (2)
  • 200
  • 2000
Signals
Solid equityLow riskGood liquidityPositive cashflowHealthy social debts

Financials

Source · NBB, 7 filings

Trend over 5 financial years

20252024202320222021
Income statement
Gross margin-29,2 k €23,8 k €188,5 k €-217,9 k €-176,6 k €
EBITDA-1,1 M €-999,5 k €-668,4 k €-704,6 k €-488,3 k €
Operating result-3,9 M €-3,6 M €-2,9 M €-3,1 M €-2,3 M €
Net result-2,3 M €-2 M €-1,8 M €-1,7 M €-1 M €
Balance sheet
Equity21,1 M €23,3 M €18 M €19,8 M €21,5 M €
Total assets21,8 M €24,8 M €20 M €21,4 M €23,9 M €
Cash2,8 M €3,2 M €1,4 M €3,2 M €6 M €
Debts692,9 k €1,4 M €2,1 M €884 k €886,4 k €
Other
Workforce10,7 ETP10,0 ETP7,9 ETP5,4 ETP4,1 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

6 active · 6 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Chen Yen-Fu
Director13/05/2025 → 02/05/2028
Christine RAINER
Director12/04/2019 → 02/05/2028
NOSHAQ PARTNERS0808.219.836Represented by Eric BRANDT
Director12/04/2019 → 02/05/2028
NRW BANKRepresented by Florian STINAUER
Director30/06/2022 → 02/05/2028Associatelisted until the 2021 accountsended
Peppermint VenturePartners GmbH0686.821.663Represented by Joachim RAUTTER
Director12/04/2019 → 02/05/2028
Yiannakis YIANNI
Managing director26/11/2018 → 02/05/2028

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
King Wai Alfred WONG
Director30/12/2021 → 2024 accounts
Artistotelis Nastos
Director12/04/2019 → 2020 accounts
Karlheinz Schmelig
Director12/04/2019 → 2020 accounts

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date01/06/202619/06/202507/06/202415/07/202320/07/202209/07/2021
General meeting06/05/202613/05/202507/05/202404/05/202330/06/202224/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 7 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202506/05/202601/06/2026FrenchPDF
Abridged model31/12/202413/05/202519/06/2025FrenchPDF
Abridged model31/12/202307/05/202407/06/2024FrenchPDF
Abridged model31/12/202204/05/202315/07/2023FrenchPDF
Abridged model31/12/202130/06/202220/07/2022FrenchPDF
Abridged model31/12/202024/06/202109/07/2021FrenchPDF
Abridged model31/12/201920/10/202003/11/2020FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

6 active · 6 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Chen Yen-Fu
Director13/05/2025 → 02/05/2028
Christine RAINER
Director12/04/2019 → 02/05/2028
NOSHAQ PARTNERS0808.219.836Represented by Eric BRANDT
Director12/04/2019 → 02/05/2028
NRW BANKRepresented by Florian STINAUER
Director30/06/2022 → 02/05/2028Associatelisted until the 2021 accountsended
Peppermint VenturePartners GmbH0686.821.663Represented by Joachim RAUTTER
Director12/04/2019 → 02/05/2028
Yiannakis YIANNI
Managing director26/11/2018 → 02/05/2028

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
King Wai Alfred WONG
Director30/12/2021 → 2024 accounts
Artistotelis Nastos
Director12/04/2019 → 2020 accounts
Karlheinz Schmelig
Director12/04/2019 → 2020 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Capital / shares03/04/2026
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Registered office21/10/2025
    SIEGE SOCIAL
    PDF
  • Mandates04/09/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates28/03/2024
    CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates28/08/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates19/10/2022
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates29/07/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates13/01/2022
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings5 filings
Mandates
Peppermint VenturePartners GmbH
NOSHAQ PARTNERS
NRW BANK
Christine RAINER
Yiannakis YIANNI
Chen Yen-Fu
King Wai Alfred WONG
Peppermint Venture Partners GMBH
Artistotelis Nastos
Maurice Buchbinder
Karlheinz Schmelig
Creathor Venture fund III
20182019202020212022202320242025202620272028
Cryotherapeutics
Avenue Alfred Deponthière 46 bte 21, 4431 LoncinAvenue Alfred Deponthière 48, 4431 Loncin
Director
Director
Director
Director
Managing director
Director
Director
Director
Director
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Avenue Alfred Deponthière 46 bte 21, 4431 LoncinCurrent
accounts 2025
Accounts 2025 · 2026-00133306
Avenue Alfred Deponthière 48, 4431 Loncin
accounts 2022 → 2024
Accounts 2024 · 2025-00170935
Rue de Bruxelles, 174, 4340 Awans
accounts 2021
Accounts 2021 · 2022-20219604

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
CryotherapeuticsCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00133306

Events

  1. 2025
    Annual accounts 2025-2,3 M €↓
  2. 2024
    Annual accounts 2024-2 M €↓
  3. 2023
    Annual accounts 2023-1,8 M €↓
  4. 2022
    Annual accounts 2022-1,7 M €↓
  5. 2021
    Annual accounts 2021-1 M €
  6. 26/11/2018
    IncorporationPublic limited company